Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Halma hires non-exec; Diurnal names new chair

Mon, 15th Nov 2021 14:15

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Halma PLC - Amersham, England-based safety equipment company - Names Sharmila Nebhrajani as an independent non-executive director, effective from December 1. Nebhrajani will also be a member of Halma's audit, remuneration & nomination committees. She is currently a non-executive director at ITV PLC and Severn Trent PLC, and chair of the National Institute for Health & Care Excellence.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company - Reports the appointment of three new members to its board. Anders Harfstrand joins as non-executive chair, while Deborah Jorn and Jean-Michel Cossery join as non-executive directors, respectively, all with immediate effect. Following the appointment of Harfstrand as non-executive chair, Sam Williams, who has held the role of interim chair since March 2020, will resume his role as a non-executive director and board representative of IP Group PLC.

----------

Angle PLC - Guilford, England-based liquid biopsy company - Appoints Todd Druley to the newly created role of chief medical officer, based in the US. The company says Druley brings highly relevant clinical and business expertise to the planning, development and commercialisation of Angle's diagnostics offerings through its clinical laboratories, regulatory filings and pharma services. Druley held the position of chief medical officer at ArcherDX Inc, a genomic analysis company, before it was acquired by Invitae Corp.

----------

Surgical Innovations Group PLC - Leeds-based medical instrument manufacturing company - Promotes Charmaine Day as chief financial officer with immediate effect. She joined Surgical Innovations in 2012 as financial controller, beginning her career in finance for Eville & Jones Ltd and later as management accountant at Ellis Fairbank PLC. In addition, the company says it considers appropriate board structure to fulfill the future strategic and governance needs of the business. The outcome of this review concludes that the optimal structure is a board of five directors comprising three non-executive directors and two executive directors. As a result, two of the current directors, Alistair Taylor and Adam Power, have indicated their intention to step down from the board with effect from the end of 2021.

----------

Induction Healthcare Group PLC - London-based hospital IT systems provider - Appoints Guy Mitchell as chief financial officer, with immediate effect. He has spent the last ten years specialising in high growth, private equity and venture capital backed software/technology companies, typically businesses with software-as-a-service models and with a global reach and customer base.

----------

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
21 Apr 2021 17:59

TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets

TRADING UPDATES: Diurnal taps GBP20 million; Victoria buys new assets

Read more
15 Apr 2021 19:37

TRADING UPDATES: HSBC announces redemption of US dollar securities

TRADING UPDATES: HSBC announces redemption of US dollar securities

Read more
26 Mar 2021 14:36

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

TRADING UPDATES: Renew to buy J Browne; Idox in good start to year

Read more
23 Feb 2021 16:23

Alkindi sales drive revenue higher for Diurnal

(Sharecast News) - Speciality pharmaceuticals company Diurnal reported 6% growth in first-half total revenue in its interim results on Tuesday, to £1.21m.

Read more
23 Feb 2021 12:28

UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal

UPDATE: Diurnal Loss Widens In First Half; Signs Chronocort Deal

Read more
23 Feb 2021 12:15

Diurnal Reports Widened Loss In First Half Despite Revenue Growth

Diurnal Reports Widened Loss In First Half Despite Revenue Growth

Read more
16 Feb 2021 15:58

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Jan 2021 09:22

Diurnal Inks Licence Agreement For Alkindi With Citrine Medicine

Diurnal Inks Licence Agreement For Alkindi With Citrine Medicine

Read more
14 Jan 2021 19:15

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

UK TRADING UPDATE SUMMARY: DWF Sets Up New Global Operating Structure

Read more
14 Jan 2021 15:18

IN BRIEF: Diurnal Pleased With Alkindi Sales In First Half

IN BRIEF: Diurnal Pleased With Alkindi Sales In First Half

Read more
13 Jan 2021 14:36

IN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort

IN BRIEF: Diurnal Inks Turkey Distribution Deal For Alkindi, Chronocort

Read more
12 Jan 2021 19:12

IN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort

IN BRIEF: Diurnal Submits Application To UK Regulators For Chronocort

Read more
11 Jan 2021 13:22

IN BRIEF: Diurnal Inks European Patent For Chronocort

IN BRIEF: Diurnal Inks European Patent For Chronocort

Read more
20 Nov 2020 18:03

IN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi

IN BRIEF: Diurnal Secures Grant Of European Patent For Alkindi

Read more
20 Nov 2020 12:04

Diurnal gets European patent for 'Alkindi'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced the grant of a patent for 'Alkindi', or hydrocortisone granules in capsules for opening, by the European Patent Office on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.